Bioactivity:

Ibrutinib-MPEA is ibrutinib derivative.�Ibrutinib is a covalent and irreversible BTK inhibitor that has been used to treat hematological malignancies.

CAS nr:

1710768-30-1

Purity:

98%

Molecular Weight:

581,71

SMILES:

NCCN1CCN(C/C=C/C(N2C[C@H](N3N=C(C4=CC=C(OC5=CC=CC=C5)C=C4)C6=C(N)N=CN=C63)CCC2)=O)CC1

Formula:

C32H39N9O2

Pathway:

Others

Target:

Others